Best Stocks To Buy Right Now

Until recently, I have been totally focused on how congressional tax proposals might affect retirement saving. I have been particularly concerned that forcing everyone to save through a Roth rather than a traditional 401(k) plan would seriously disrupt savings patterns and cause many workers especially the lower paid and those who are liquidity constrained to reduce their saving.

For the moment, it seems that Rothification is off the table. This hiatus makes it possible to step back and look at the big picture. The story, in my view, is not the details of the House or Senate bill and whether the middle class comes out plus or minus a thousand dollars, but rather what tax cuts at this time do to our fiscal structure and their impact on Social Security, Medicare, and Medicaid down the road.

Best Stocks To Buy Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

Best Stocks To Buy Right Now: iShares Intermediate Credit Bond (CIU)

Advisors’ Opinion:


    For the details of ARKANSAS FINANCIAL GROUP, INC.’s stock buys and sells, go to

    These are the top 5 holdings of ARKANSAS FINANCIAL GROUP, INC.SPDR Dow Jones Industrial Average (DIA) – 239,571 shares, 25.69% of the total portfolio. Shares reduced by 2.73%iShares Core S&P Mid-Cap (IJH) – 277,760 shares, 23.14% of the total portfolio. Shares added by 0.52%iShares 1-3 Year Credit Bond ETF (CSJ) – 400,939 shares, 18.49% of the total portfolio. Shares added by 1.16%iShares Intermediate Credit Bond ETF (CIU) – 229,423 shares, 10.93% of the total portfolio. Shares reduced by 5.93%Vanguard Mid-Cap (VO) – 82,652 shares, 5.66% of the total p

Best Stocks To Buy Right Now: Foundation Medicine, Inc.(FMI)

Advisors’ Opinion:

  • [By Todd Campbell, Rich Smith, and Neha Chamaria]

    Great stocks that disrupt big markets and reward shareholders with massive long-term returns, such as eBay (NASDAQ:EBAY), don’t come around every day, so when they do, investors should consider adding them to their portfolios. These Motley Fool investors think Roku (NASDAQ:ROKU), Raven Industries (NASDAQ:RAVN), and Foundation Medicine (NASDAQ:FMI) fall into that camp. Are they worth buying right now? Read on to learn more about these stocks and what could cause them to deliver envy-inspiring returns in the future.

  • [By Todd Campbell]

    Technology stocks are staples in growth portfolios because of their eye-popping revenue growth, but technology isn’t the only sector of the stock market that boasts fast-growing companies. For example, many healthcare stocks are growing at rates that Silicon Valley would envy. In fact, Foundation Medicine (NASDAQ:FMI), Exelixis Corp (NASDAQ:EXEL), and Teladoc (NYSE:TDOC) all reported year-over-year sales growth north of 100% in first-quarter 2018.

Best Stocks To Buy Right Now: Digirad Corporation(DRAD)

Advisors’ Opinion:

  • [By ]

    Some of these are even smaller nano-caps, such as medical device maker Digirad (Nasdaq: DRAD), whose entire market value is just $36 million.

    There is absolutely nothing wrong with small businesses. I own shares of quite a few in my personal account. But for the most part, I use them to fill out the growth sleeve of my portfolio and don’t consider them stable income producers.

Best Stocks To Buy Right Now: VOC Energy Trust(VOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.

Leave a Reply

Your email address will not be published. Required fields are marked *